Profound Medical Corp (PRN.TO)
10.01
-0.07
(-0.69%)
CAD |
TSX |
May 31, 16:00
Profound Medical Revenue (Quarterly): 2.575M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 2.575M |
December 31, 2023 | 2.735M |
September 30, 2023 | 2.319M |
June 30, 2023 | 2.153M |
March 31, 2023 | 2.516M |
December 31, 2022 | 1.700M |
September 30, 2022 | 2.654M |
June 30, 2022 | 2.582M |
March 31, 2022 | 1.727M |
December 31, 2021 | 1.257M |
September 30, 2021 | 3.194M |
June 30, 2021 | 3.225M |
March 31, 2021 | 0.8999M |
December 31, 2020 | 3.752M |
September 30, 2020 | 2.980M |
Date | Value |
---|---|
June 30, 2020 | 1.422M |
March 31, 2020 | 1.556M |
December 31, 2019 | 2.785M |
September 30, 2019 | 0.6806M |
June 30, 2019 | 0.5851M |
March 31, 2019 | 1.470M |
December 31, 2018 | 1.612M |
September 30, 2018 | 0.3072M |
June 30, 2018 | 0.2093M |
March 31, 2018 | 0.3681M |
December 31, 2017 | 1.870M |
September 30, 2017 | 1.481M |
June 30, 2017 | 0.99M |
March 31, 2017 | 0.5873M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.5851M
Minimum
Jun 2019
3.752M
Maximum
Dec 2020
2.165M
Average
2.418M
Median
Revenue (Quarterly) Benchmarks
Biocure Technology Inc | -- |
Core One Labs Inc | 0.0937M |
Nova Mentis Life Science Corp | 0.0283M |
Nanosphere Health Sciences Inc | -- |
Lobe Sciences Ltd | -- |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -8.357M |
Total Expenses (Quarterly) | 12.66M |
EPS Diluted (Quarterly) | -0.3505 |
Enterprise Value | 197.56M |
Gross Profit Margin (Quarterly) | 66.44% |
Profit Margin (Quarterly) | -324.6% |
Earnings Yield | -17.40% |
Normalized Earnings Yield | -16.95 |